#$%^&*AU2014233615B220160811.pdf#####ABSTRACT The present invention provides anti-N3pGlu AP antibodies or antigen-binding fragment thereof. In addition, the present invention provides the use of the anti-N3pGlu AP antibodies or antigen-binding fragment thereof for the treatment of Alzheimer's disease.